Research interests
Dr. Golden’s primary research interest centers around identifying endocrine risk factors associated with the development of diabetes and cardiovascular disease through the incorporation of measures of hormonal function into the design of clinical trials of cardiovascular risk modification, observational studies of incident cardiovascular disease and diabetes, and studies evaluating diabetic complications. Her research has used the tools of observational epidemiology to identify endocrine risk factors associated with adverse metabolic outcomes and it has focused on two areas: (1) the hormones of the hypothalamic-pituitary-gonadal axis (sex hormones) and (2) the hormones of the hypothalamic-pituitary-adrenal (HPA) axis (cortisol).
Recent publications
- Endogenous Post-menopausal Hormones and Carotid Atherosclerosis: A Case-Control Study of the Atherosclerosis Risk in Communities Cohort
- Risk Factor Clusters Related to Insulin Resistance and Their Synergistic Effects on Subclinical Atherosclerosis: The Atherosclerosis Risk In Communities Study
- Prospective Investigation of Autonomic Nervous System Function and the Development of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study
- Fasting Plasma Free Fatty Acids and Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study
- Depressive Symptoms and the Risk of Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities Study
- Glycated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
- Glucose and Insulin Components of the Metabolic Syndrome are Associated with Hyperandrogenism in Post-menopausal Women: The Atherosclerosis Risk In Communities Study
- Prevalence of Coronary Heart Disease and Carotid Arterial Thickening in Patients with the Metabolic Syndrome, the ARIC Study
- The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study
- Endogenous Post-menopausal Hormones and Serum Lipids
